Senti Biosciences Files 8-K: Director Departs, Disclosures Made
Ticker: SNTI · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1854270
Sentiment: neutral
Topics: director-departure, executive-compensation, regulation-fd
TL;DR
Senti Bio director Pescatore out, other exec comp & Reg FD updates filed Feb 23.
AI Summary
Senti Biosciences, Inc. announced on February 23, 2025, the departure of Director Dr. Philip P. Pescatore. The company also reported on compensatory arrangements for certain officers and provided a Regulation FD disclosure. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing signals a change in the board of directors and provides important updates on executive compensation and regulatory disclosures, which could impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — Director departures and executive compensation disclosures can indicate internal changes or financial pressures that may affect the company's future performance.
Key Numbers
- 20250223 — Report Date (The date of the earliest event reported in the filing.)
- 15 — Public Document Count (Indicates the number of documents included in the filing.)
Key Players & Entities
- Senti Biosciences, Inc. (company) — Registrant
- Dr. Philip P. Pescatore (person) — Departing Director
- February 23, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40440 (filing_id) — SEC File Number
FAQ
Who is Dr. Philip P. Pescatore and what was his role at Senti Biosciences?
Dr. Philip P. Pescatore was a Director at Senti Biosciences, Inc. His departure is noted in the filing dated February 23, 2025.
What are the main items reported in this 8-K filing?
This 8-K filing reports the departure of a director, compensatory arrangements of certain officers, and includes a Regulation FD disclosure, along with financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on February 23, 2025.
What is Senti Biosciences, Inc.'s state of incorporation and SEC file number?
Senti Biosciences, Inc. is incorporated in Delaware and its SEC file number is 001-40440.
What type of business is Senti Biosciences, Inc. primarily involved in?
Senti Biosciences, Inc. is primarily involved in Biological Products (No Diagnostic Substances), with a Standard Industrial Classification code of 2836.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 by Dr. Philip P. Pescatore regarding Senti Biosciences, Inc. (SNTI).